Largest Hong Kong (HSI) Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
3692 Hansoh Pharmaceutical Group	HK$19.80	13.0%	48.9%	HK$117.5b	HK$23.65	PE23.3x	E6.4%	2.0%
2269 WuXi Biologics (Cayman)	HK$26.00	11.6%	42.5%	HK$106.5b	HK$22.53	PE37.8x	E16.3%	n/a
1801 Innovent Biologics	HK$41.70	11.2%	4.8%	HK$68.3b	HK$53.36	PS8.6x	E44.0%	n/a
9926 Akeso	HK$68.95	14.5%	51.4%	HK$61.9b	HK$76.99	PS30.8x	E43.8%	n/a
1177 Sino Biopharmaceutical	HK$3.34	3.4%	6.4%	HK$60.7b	HK$4.49	PE26.5x	E12.6%	1.7%
1093 CSPC Pharmaceutical Group	HK$5.01	4.4%	-20.7%	HK$57.6b	HK$7.04	PE10.4x	E1.3%	6.4%
6990 Sichuan Kelun-Biotech Biopharmaceutical	HK$213.40	16.9%	100.4%	HK$48.5b	HK$222.81	PS24.1x	E5.1%	n/a
2268 WuXi XDC Cayman	HK$37.65	25.3%	111.8%	HK$45.1b	HK$36.86	PE70.9x	E26.9%	n/a
3320 China Resources Pharmaceutical Group	HK$5.48	0.9%	-0.9%	HK$34.4b	HK$7.21	PE8.5x	E6.8%	3.2%
2228 XtalPi Holdings	HK$8.47	28.1%	n/a	HK$28.9b	HK$8.58	PS136.7x	E90.7%	n/a
1548 Genscript Biotech	HK$13.22	10.4%	-11.3%	HK$28.4b	HK$22.72	PS3.6x	E111.3%	0%
1877 Shanghai Junshi Biosciences	HK$13.74	9.7%	10.3%	HK$26.5b	HK$15.53	PS7.1x	E47.4%	n/a
3933 United Laboratories International Holdings	HK$13.24	3.0%	62.1%	HK$24.1b	HK$12.11	PE7.7x	E4.5%	4.5%
867 China Medical System Holdings	HK$8.30	7.5%	-35.2%	HK$20.1b	HK$11.00	PE13.5x	E21.4%	5.1%
2096 Simcere Pharmaceutical Group	HK$7.90	12.9%	42.3%	HK$19.6b	HK$9.07	PS2.9x	E71.6%	2.1%
512 Grand Pharmaceutical Group	HK$4.80	4.6%	31.5%	HK$16.8b	HK$6.63	PE7x	E2.3%	5.4%
1530 3SBio	HK$6.90	2.5%	28.3%	HK$16.3b	HK$8.40	PE9.1x	E16.2%	3.5%
9969 InnoCare Pharma	HK$7.56	15.6%	47.4%	HK$15.4b	HK$8.43	PS13.8x	E27.3%	n/a
9995 RemeGen	HK$16.48	5.5%	-23.3%	HK$14.7b	HK$25.04	PS5.4x	E51.9%	n/a
1952 Everest Medicines	HK$45.10	20.9%	123.3%	HK$14.5b	HK$37.83	PS32.4x	E90.1%	n/a
6855 Ascentage Pharma Group International	HK$41.45	17.1%	62.5%	HK$14.0b	HK$51.15	PS14.5x	E53.7%	n/a
6826 Shanghai Haohai Biological Technology	HK$26.70	1.5%	2.6%	HK$13.1b	HK$42.57	PE13.6x	E20.1%	3.2%
6185 CanSino Biologics	HK$35.00	6.4%	99.8%	HK$12.5b	HK$32.68	PS10.8x	E128.6%	0%
2696 Shanghai Henlius Biotech	HK$21.30	1.2%	64.6%	HK$11.6b	HK$24.59	PE15.6x	S9.9%	n/a